Published in Infect Immun on July 01, 1979
Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol (1986) 4.48
Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis. Infect Immun (1981) 2.94
Isolation and characterization of isogenic pairs of domed hemolytic and flat nonhemolytic colony types of Bordetella pertussis. Infect Immun (1982) 2.47
Hemagglutination by Bordetella bronchiseptica. J Clin Microbiol (1982) 1.03
Separation and characterization of two distinct hemagglutinins contained in purified leukocytosis-promoting factor from Bordetella pertussis. Biochim Biophys Acta (1976) 3.30
Leukocytosis-promoting factor of Bordetella pertussis. 3. Its identity with protective antigen. Infect Immun (1974) 2.43
Adsorption of protective antigen of Hemophilus pertussis on human red cell stromata. Proc Soc Exp Biol Med (1950) 2.37
Production, extraction and purification of haemagglutinin of Haemophilus pertussis. J Gen Microbiol (1952) 1.80
Studies on the hemagglutinin of Hemophilus pertussis. J Immunol (1950) 1.50
The haemagglutinin of Haemophilus pertussis. IV. Reactions and antibody response in babies and children following the administration of haemagglutinin absorbed on aluminum phosphate. Aust J Exp Biol Med Sci (1951) 0.98
Studies on the direct hemagglutinin in fluid culture supernatant of H. pertussis. Kitasato Arch Exp Med (1953) 0.90
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
Amino acid sequence of the human fibronectin receptor. J Cell Biol (1987) 4.08
Separation and characterization of two distinct hemagglutinins contained in purified leukocytosis-promoting factor from Bordetella pertussis. Biochim Biophys Acta (1976) 3.30
Biological activities of crystalline pertussigen from Bordetella pertussis. Infect Immun (1981) 3.16
Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis. Infect Immun (1981) 2.94
Amantadine and pneumonia. Lancet (1999) 2.69
cDNA and amino acid sequences of the cell adhesion protein receptor recognizing vitronectin reveal a transmembrane domain and homologies with other adhesion protein receptors. Proc Natl Acad Sci U S A (1986) 2.58
Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem (1999) 2.44
Leukocytosis-promoting factor of Bordetella pertussis. 3. Its identity with protective antigen. Infect Immun (1974) 2.43
Studies on sea-snake venoms. Crystallization of erabutoxins a and b from Laticauda semifasciata venom. Biochem J (1966) 2.37
Amino acid sequence of the vitronectin receptor alpha subunit and comparative expression of adhesion receptor mRNAs. J Biol Chem (1987) 2.29
Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan. Ann Neurol (1998) 2.25
Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase [corrected]. Nature (1994) 2.22
Leucocytosis-promoting factor of Bordetella pertussis. I. Purification and characterization. Infect Immun (1972) 2.11
Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int (2006) 2.10
Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology (1992) 2.06
Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet (1995) 2.03
Symptomatic myopathy associated with interferon therapy for chronic hepatitis C. Lancet (1995) 1.99
Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc Natl Acad Sci U S A (1997) 1.91
Expression of pertussis toxin correlates with pathogenesis in Bordetella species. J Infect Dis (1989) 1.82
Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene. Ann Neurol (1997) 1.81
Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients. Ann Thorac Surg (2000) 1.78
Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Cell Immunol (1982) 1.77
Risk factors of aspiration pneumonia in Alzheimer's disease patients. Gerontology (2001) 1.77
Adult-onset spinocerebellar dysfunction caused by a mutation in the gene for the alpha-tocopherol-transfer protein. N Engl J Med (1995) 1.77
Leukocytosis-promoting factor of Bordetella pertussis. II. Biological properties. Infect Immun (1973) 1.77
Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. Am J Physiol (1984) 1.76
Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett (1997) 1.74
Reassessment of Fura-2 and the ratio method for determination of intracellular Ca2+ concentrations. Cell Calcium (1991) 1.72
Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. J Immunol (1999) 1.71
Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest (1989) 1.69
Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. J Biol Chem (1990) 1.67
Fimbrial hemagglutinin in stationary and shake cultures of Bordetella pertussis. Infect Immun (1979) 1.65
Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation (2000) 1.65
Molecular cloning of pertussis toxin genes. Nucleic Acids Res (1986) 1.64
Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ Res (2001) 1.63
CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects. Neurology (2002) 1.58
Delayed-onset ataxia in mice lacking alpha -tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc Natl Acad Sci U S A (2001) 1.57
ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis. Science (1988) 1.57
Complications associated with transvenous embolisation of cavernous dural arteriovenous fistula. Acta Neurochir (Wien) (1999) 1.55
C-type natriuretic peptide (CNP) in rats and humans. Endocrinology (1991) 1.54
The inhibition of neutrophil granule enzyme secretion and chemotaxis by pertussis toxin. J Cell Biol (1985) 1.53
Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus. Eur J Neurol (2012) 1.52
Pertussis but not cholera toxin inhibits the stimulated increase in actin association with the cytoskeleton in rabbit neutrophils: role of the "G proteins" in stimulus-response coupling. Biochem Biophys Res Commun (1985) 1.51
Endovascular therapy of 500 small asymptomatic unruptured intracranial aneurysms. AJNR Am J Neuroradiol (2012) 1.49
Effects of intraaortic balloon position on renal artery blood flow. Ann Thorac Surg (1992) 1.48
Identification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type I. Proc Natl Acad Sci U S A (2000) 1.47
Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors. FEBS Lett (2000) 1.47
A simple in vitro method for studies on chemotaxis. Proc Soc Exp Biol Med (1974) 1.46
Crystallization of pertussigen from Bordetella pertussis. Infect Immun (1981) 1.45
Cerebrospinal fluid tau protein levels in demented and nondemented alcoholics. Alcohol Clin Exp Res (1999) 1.43
Brain acetylhydrolase that inactivates platelet-activating factor is a G-protein-like trimer. Nature (1997) 1.42
CSF tau protein: a new prognostic marker for Guillain-Barré syndrome. Neurology (2006) 1.40
Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis. J Biol Chem (2001) 1.39
SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells. Exp Cell Res (1996) 1.38
Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression. Neurology (2004) 1.36
Transvenous embolization of dural carotid cavernous fistulas: a series of 44 consecutive patients. AJNR Am J Neuroradiol (2009) 1.32
Purification and characterization of bovine brain platelet-activating factor acetylhydrolase. J Biol Chem (1993) 1.30
Hemagglutinin antibody response of normal and Aleutian disease-affected mink to keyhole limpet hemocyanin. J Immunol (1970) 1.29
Detection of subunits of pertussis toxin in Tn5-induced Bordetella mutants deficient in toxin biological activity. Infect Immun (1987) 1.28
Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum Genet (1997) 1.28
Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group. Arch Surg (1998) 1.28
Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking. J Biol Chem (1997) 1.27
Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig Dis Sci (1986) 1.27
Stereocontrol in intramolecular hydrosilylation of allyl and homoallyl alcohols: a new approach to the stereoselective synthesis of 1,3-diol skeletons. J Am Chem Soc (1986) 1.26
Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression. Neuroscience (1999) 1.25
Gas6 induces mesangial cell proliferation via latent transcription factor STAT3. J Biol Chem (2001) 1.24
Molecular mechanisms of vitamin E transport. Annu Rev Nutr (1999) 1.24
Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide. Circ Res (1991) 1.23
Alpha-tocopherol transfer protein is important for the normal development of placental labyrinthine trophoblasts in mice. J Biol Chem (2000) 1.22
Relation between incidence of pneumonia and protective reflexes in post-stroke patients with oral or tube feeding. J Intern Med (2000) 1.22
Brain natriuretic peptide is a novel cardiac hormone. Biochem Biophys Res Commun (1989) 1.21
Inhibition of the coated vesicle proton pump and labeling of a 17,000-dalton polypeptide by N,N'-dicyclohexylcarbodiimide. J Biol Chem (1987) 1.20
Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products. J Biol Chem (2000) 1.20
Regulation of Pseudomonas aeruginosa hemF and hemN by the dual action of the redox response regulators Anr and Dnr. Mol Microbiol (1998) 1.20
Elicitation of experimental allergic encephalomyelitis (EAE) in mice with the aid of pertussigen. Cell Immunol (1984) 1.20
Inhibition of acyl-CoA: cholesterol acyltransferase activity by cyclodepsipeptide antibiotics. J Antibiot (Tokyo) (1992) 1.20
Repetitive cocaine administration decreases neurogenesis in adult rat hippocampus. Ann N Y Acad Sci (2004) 1.19
Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease. Ann Neurol (2001) 1.18
Role of oxidized LDL in atherosclerosis. Ann N Y Acad Sci (2001) 1.18
Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes. Proc Natl Acad Sci U S A (1990) 1.18
Protection against oxidative stress-induced cell death by intracellular platelet-activating factor-acetylhydrolase II. J Biol Chem (1997) 1.18
Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice. J Exp Med (1983) 1.18
Presenilin-1 polymorphism and Alzheimer's disease. Lancet (1996) 1.18
Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: immunohistochemical study using formic acid pretreatment of tissue sections. Neurosci Lett (1994) 1.18
Gene cluster for dissimilatory nitrite reductase (nir) from Pseudomonas aeruginosa: sequencing and identification of a locus for heme d1 biosynthesis. J Bacteriol (1997) 1.18
Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis. Am J Pathol (2001) 1.17
Expression cloning of a novel scavenger receptor from human endothelial cells. J Biol Chem (1997) 1.17
High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci U S A (1991) 1.17
Molecular cloning of a non-isopeptide-selective human endothelin receptor. Biochem Biophys Res Commun (1991) 1.17
Direct association of LIS1, the lissencephaly gene product, with a mammalian homologue of a fungal nuclear distribution protein, rNUDE. FEBS Lett (2000) 1.17
Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer disease. Arch Neurol (2000) 1.17
Regulation of intestinal Na+-dependent phosphate co-transporters by a low-phosphate diet and 1,25-dihydroxyvitamin D3. Biochem J (1999) 1.16
Primary structure of alpha-tocopherol transfer protein from rat liver. Homology with cellular retinaldehyde-binding protein. J Biol Chem (1993) 1.16
Vascular permeability changes in the central nervous system of rats with hyperacute experimental allergic encephalomyelitis induced with the aid of a substance from Bordetella pertussis. Infect Immun (1978) 1.16